UBS O'Connor’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History

UBS O'Connor’s Portfolio SANB Stock Details SANB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-267,649	Closed	-$2.71M	–	896
2022 Q3	$2.71M	Hold	267,649	–	–	0.03%	472
2022 Q2	$2.69M	Buy	+267,649	New	+$2.69M	0.03%	492
2022 Q1	–	Sell	-262,932	Closed	-$2.61M	–	775
2021 Q4	$2.61M	Buy	+262,932	New	+$2.61M	0.03%	437

UBS O'Connor's SANB Position: Q4 2022 in Review

UBS O'Connor sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q4 2022, closing a stake of 267,649 shares — an estimated $2.71M sold.

UBS O'Connor first reported a position in SANB in Q4 2021 and held it in 3 quarters. The position peaked at $2.71M in Q3 2022. 0 funds tracked by Wall St. Rank hold SANB as of Q4 2022.

UBS O'Connor reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 267,649 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q4 2022, an estimated $2.71M.
UBS O'Connor first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 3 quarters.
UBS O'Connor's Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $2.71M in Q3 2022.
0 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.